Yong, Kol Jia; Bassères, Daniela Sanchez 
; Welner, Robert S; Zhang, Wen Cai; Yang, Henry; Yan, Benedict; Jorda, Meritxell Alberich; Zhang, Junyan; Pontes, Lorena Lobo de Figueiredo; Battelli, Chiara; Hetherington, Christopher J; Ye, Min; Zhang, Hong; Maroni, Giorgia; O'Brien, Karen; Magli, Maria Cristina; Borczuk, Alain C; Varticovski, Lyuba; Kocher, Olivier; Zhang, Pu; Moon, Young-Choon; Sydorenko, Nadiya; Cao, Liangxian; Davis, Thomas W; Thakkar, Bhavin M; Soo, Ross A; Iwama, Atsushi; Lim, Bing; Halmos, Balazs; Neuberg, Donna; Tenen, Daniel G; Levantini, Elena
Source: Science Translational Medicine. Unidade: IQ
Subjects: NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YONG, Kol Jia et al. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, v. 8, n. 350, p. 1-10 art. 350ra104, 2016Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aad6066. Acesso em: 10 nov. 2024.APA
Yong, K. J., Bassères, D. S., Welner, R. S., Zhang, W. C., Yang, H., Yan, B., et al. (2016). Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, 8( 350), 1-10 art. 350ra104. doi:10.1126/scitranslmed.aad6066NLM
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066Vancouver
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
